Compare NECB & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NECB | SMTI |
|---|---|---|
| Founded | 1934 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 282.4M | 186.9M |
| IPO Year | N/A | N/A |
| Metric | NECB | SMTI |
|---|---|---|
| Price | $23.40 | $26.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $41.00 |
| AVG Volume (30 Days) | ★ 51.8K | 51.4K |
| Earning Date | 01-28-2026 | 11-12-2025 |
| Dividend Yield | ★ 4.30% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.21 | N/A |
| Revenue | ★ $102,569,000.00 | $101,877,532.00 |
| Revenue This Year | $1.90 | $21.60 |
| Revenue Next Year | $6.93 | $16.70 |
| P/E Ratio | $7.24 | ★ N/A |
| Revenue Growth | N/A | ★ 30.52 |
| 52 Week Low | $19.27 | $18.90 |
| 52 Week High | $28.92 | $38.68 |
| Indicator | NECB | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 72.41 | 62.13 |
| Support Level | $21.30 | $20.06 |
| Resistance Level | $22.19 | $24.96 |
| Average True Range (ATR) | 0.60 | 1.23 |
| MACD | 0.27 | 0.90 |
| Stochastic Oscillator | 84.22 | 87.01 |
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.